To Fe, or not to Fe, that is the question

In this issue of Blood, Hod et al1 present results of the Donor Iron Deficiency Study (DIDS), a randomized controlled trial that demonstrates that iron repletion in iron-deficient blood donors fails to improve posttransfusion recovery of a subsequently donated red blood cell (RBC) unit or the qual-ity of life and cognitive performance of the blood donor.

Automated summary

In this study, it was found that iron repletion in iron-deficient blood donors does not improve posttransfusion recovery of subsequently donated red blood cell units or the quality of life and cognitive performance of the blood donors.